{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T19:18:38Z","timestamp":1785007118797,"version":"3.55.0"},"reference-count":26,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T00:00:00Z","timestamp":1442880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>This study aims to determine the most efficacious dose of Botulinum neurotoxin type A (BoNT-A) in reducing sialorrhea in Asian adults with neurological diseases.  A prospective, double-blind randomized controlled trial was conducted over 24 weeks. Thirty patients with significant sialorrhea were randomly assigned to receive a BoNT-A (Dysport\u00ae) injection into the submandibular and the parotid glands bilaterally via an ultrasound guidance. The total dose given per patient was either BoNT-A injection of (i) 50 U; (ii) 100 U; or (iii) 200 U. The primary outcome was the amount of saliva reduction, measured by the differential weight (wet versus dry) of intraoral dental gauze at baseline and at 2, 6, 12, and 24 weeks after injection. The secondary outcome was the subjective report of drooling using the Drooling Frequency and Severity Scale (DFS). Saliva reduction was observed in response to all BoNT-A doses in 17 patients who completed the assessments. Although no statistically significant difference among the doses was found, the measured reduction was greater in groups that received higher doses (100 U and 200 U). The group receiving 200 U of Dysport\u00ae showed the greatest reduction of saliva until 24 weeks and reported the most significant improvement in the DFS score.<\/jats:p>","DOI":"10.3390\/toxins7093758","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T15:36:54Z","timestamp":1442936214000},"page":"3758-3770","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["A Double-Blind Randomized Controlled Trial Investigating  the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases"],"prefix":"10.3390","volume":"7","author":[{"given":"Mazlina","family":"Mazlan","sequence":"first","affiliation":[{"name":"Department of Rehabilitation Medicine, Faculty of Medicine, University of Malaya, 12th Floor, Menara Selatan, University Malaya Medical Centre, Jalan Universiti, 59100 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Rajasegaran","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Faculty of Medicine, University of Malaya, 12th Floor, Menara Selatan, University Malaya Medical Centre, Jalan Universiti, 59100 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Engkasan","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation Medicine, Faculty of Medicine, University of Malaya, 12th Floor, Menara Selatan, University Malaya Medical Centre, Jalan Universiti, 59100 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouzreiah","family":"Nawawi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, 12th Floor,  Menara Selatan, University Malaya Medical Centre, Jalan Universiti, 59100 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khean-Jin","family":"Goh","sequence":"additional","affiliation":[{"name":"Neurology Division, Department of Medicine, Faculty of Medicine, University of Malaya,  Jalan Universiti, 50603 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saini","family":"Freddy","sequence":"additional","affiliation":[{"name":"KPJ KL Rehabilitation Centre, Tawakkal Health Centre, 202A, Jalan Pahang, 53000 Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.70.4.538","article-title":"Treatment of sialorrhea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders","volume":"70","author":"Porta","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_2","first-page":"E511","article-title":"Salivary gland application of botulinum toxin for the treatment of sialorrhea","volume":"12","year":"2007","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1469-8749.1992.tb11444.x","article-title":"Surgical management of drooling","volume":"34","author":"Blasco","year":"1992","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.parkreldis.2007.01.007","article-title":"Botulinum toxin A for drooling in Parkinson\u2019s disease: A pilot study to compare submandibular to parotid gland injections","volume":"13","author":"Kalf","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.clineuro.2008.09.001","article-title":"Treatment of sialorrhea in children with cerebral palsy: A double-blind placebo controlled trial","volume":"111","author":"Alrefai","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling: A controlled clinical trial","volume":"114","author":"Jongerius","year":"2004","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s11910-014-0511-3","article-title":"An update on the use of botulinum toxin therapy in Parkinson\u2019s disease","volume":"15","author":"Mills","year":"2015","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0194599812465059","article-title":"Botulinum toxin for the treatment of sialorrhea: A meta-analysis","volume":"148","author":"Vashishta","year":"2013","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/mds.23473","article-title":"Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study inpatients with amyotrophic lateral sclerosis or Parkinson\u2019s disease","volume":"26","author":"Guidubaldi","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mds.10420","article-title":"Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin A in the treatment of drooling in parkinsonism","volume":"18","author":"Mancini","year":"2003","journal-title":"Mov. Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: Differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur. J. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1468-1331.2010.03131.x","article-title":"Botulinum toxin assessment, intervention and aftercare for pediatric and adult drooling; international consensus statement","volume":"17","author":"Reddihough","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MRR.0b013e328332f5e0","article-title":"The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: An international survey","volume":"33","author":"Bakheit","year":"2010","journal-title":"Int. J. Rehabil. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","article-title":"Three treatment approaches and clinical factors in the reduction of drooling","volume":"3","author":"Greenberg","year":"1988","journal-title":"Dysphagia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea: Anatomy, pathophyisology and treatment with emphasis on the role of botulinum toxins","volume":"5","author":"Lakraj","year":"2013","journal-title":"Toxins"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1469-8749.2011.03952.x","article-title":"Botulinum toxin type B for sialorrhea in children with cerebral palsy: A randomized trial comparing three doses","volume":"53","author":"Basciani","year":"2011","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/ane.12309","article-title":"Repeated treatments of drooling with botulinum toxin B in neurology","volume":"131","author":"Daugaard","year":"2015","journal-title":"Acta Neurol. Scand."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00455-014-9535-8","article-title":"The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis\/motor neurone disease: A systematic review","volume":"29","author":"Squires","year":"2014","journal-title":"Dysphagia"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2147\/NDT.S1612","article-title":"Neurologic uses of botulinum neurotoxin type A","volume":"3","author":"Ney","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejpn.2014.05.007","article-title":"Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: A review","volume":"18","author":"Porte","year":"2014","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.69.1.121","article-title":"Injections of botulinum toxin A into the salivary glands improve sialorrhea in amyotrophic lateral sclerosis","volume":"69","author":"Giess","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bjoms.2014.03.017","article-title":"Dysphagia as a complication of botulinum toxin injection to treat drooling","volume":"52","author":"Tighe","year":"2014","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Jost, W.H. (2015). The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson\u2019s disease. J. Neural. Transm.","DOI":"10.1007\/s00702-015-1416-2"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.61.9.1279","article-title":"A randomized trial of botulinum toxin A for treatment of drooling","volume":"61","author":"Lipp","year":"2003","journal-title":"Neurology"},{"key":"ref_25","first-page":"CD006981","article-title":"Treatment for sialorrhea (excessive saliva) in people with motor neuron disease\/amyotrophic lateral sclerosis","volume":"11","author":"Young","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","article-title":"Drooling in Parkinson\u2019s disease: A review","volume":"20","author":"Srivanitchapoom","year":"2014","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/7\/9\/3758\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:49:02Z","timestamp":1760215742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/7\/9\/3758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9]]}},"alternative-id":["toxins7093758"],"URL":"https:\/\/doi.org\/10.3390\/toxins7093758","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]}}}